Kinvent

Private

MontpellierHealthcare & Life Scienceshttps://kinvent.com/

Last Round

Series B

Jan 18, 2024

Total Funding Raised

$25.3M

Company Overview

Kinvent is a monitoring equipment company that develops a sensor-based device intended to monitor athletic movements and enhance physical rehabilitation and sports biomechanics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Vertical SaaS, Health IoT, Healthcare Analytics, Sports Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

rehabilitation technologyphysiotechrehab techconnected sensorsphysical therapy technologysports techbiomechanics platformstrength testingobjective measurementsports performance technologydynamometerforce plateshuman performancemovement analysisbiofeedback systemwearable sensorsgoniometersurface EMGpose detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kinvent Comps

Public and private peers based on sector, stage, and business model.

Kinvent comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kinvent Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jan 18, 2024
Series A	Dec 2, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Athanase Kollias

CEO

Executive Team

Kinvent Investors

Notable investors and investment history

Kinvent investors
Investor	Rounds
Sofilaro	Series A, Series B
Uni.Fund	Series A, Series B, Seed
Les Business Angels des Grandes Ecoles	Series A, Series B, Seed
Bpifrance	Series A
Eurazeo	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 24, 2026
Monthly visitors grew 118% MoM, reaching 29.8K.
May 2, 2025
Monthly visitors grew 101% MoM, reaching 16.5K.

View all signals

Kinvent Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Kinvent Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kinvent's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontpellier

Employee Range92

Year Founded2017

Last FundingJan 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.